Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Complement activation at the interface between adipocytes and cancer cells drives tumor progression
Andres Valdivia, Ana Maria Isac, Horacio Cardenas, Guangyuan Zhao, Yaqi Zhang, Hao Huang, Jian-Jun Wei, Mauricio Cuello-Fredes, Sumie Kato, Fernán Gómez-Valenzuela, Francoise Gourronc, Aloysius Klingelhutz, Daniela Matei
Andres Valdivia, Ana Maria Isac, Horacio Cardenas, Guangyuan Zhao, Yaqi Zhang, Hao Huang, Jian-Jun Wei, Mauricio Cuello-Fredes, Sumie Kato, Fernán Gómez-Valenzuela, Francoise Gourronc, Aloysius Klingelhutz, Daniela Matei
View: Text | PDF
Research Article Cell biology Oncology

Complement activation at the interface between adipocytes and cancer cells drives tumor progression

  • Text
  • PDF
Abstract

The omentum is the primary site of metastasis for ovarian cancer (OC). Interactions between cancer cells and adipocytes drive an invasive and prometastatic phenotype. Here we studied cancer cell–adipocyte crosstalk by using a direct coculture model with immortalized human visceral nondiabetic pre-adipocytes (VNPADs) and OC cells. We demonstrated increased proliferation, invasiveness, and resistance to cisplatin of cocultured compared with monocultured OC cells. RNA sequencing of OC cells from coculture versus monoculture revealed significant transcriptomic changes, identifying over 200 differentially expressed genes common to OVCAR5 and OVCAR8 cell lines. Enriched pathways included PI3K/AKT and complement activation. Lipid transfer into OC cells from adipocytes induced upregulation of complement C3 and C5 proteins. Inhibiting C3 or C5 reversed the invasive phenotype and C3 knockdown reduced tumor progression in vivo. Increased C3 expression was observed in omental implants compared with primary ovarian tumors and C3 secretion was higher in OC ascites from high-BMI versus low-BMI patients. C3 upregulation in OC cells involved activation of the ATF4-mediated integrated stress response (ISR). Overall, adipocyte–cancer cell interactions promoted invasiveness and tumorigenesis via lipid transfer, activating the ISR, and upregulating complement proteins C3 and C5.

Authors

Andres Valdivia, Ana Maria Isac, Horacio Cardenas, Guangyuan Zhao, Yaqi Zhang, Hao Huang, Jian-Jun Wei, Mauricio Cuello-Fredes, Sumie Kato, Fernán Gómez-Valenzuela, Francoise Gourronc, Aloysius Klingelhutz, Daniela Matei

×

Figure 7

Adipocyte coculture increases activation of the integrated stress pathway response in OC cells.

Options: View larger image (or click on image) Download as PowerPoint
Adipocyte coculture increases activation of the integrated stress pathwa...
(A) Main regulator analysis (Metascape) shows ATF4 (red arrow) as the main regulator of OVCAR5 and OVCAR8 common genes. (B and C) Effects of coculture of OVCAR5 (B) and OVCAR8 (C) cells with cocultured adipocytes on mRNA expression levels of ATF4 measured by qRT-PCR (n = 3). (D and E) Western blot of integrated stress pathway response proteins in OVCAR8 (D) and OVCAR5 (E) cells cultured in regular media supplemented with none or 10% lipid mixture or following coculture with adipocytes. (F) shRNA knockdown of ATF4 gene expression verified by qRT-PCR in OVCAR5 cells (n = 3). “A” and “B” indicate 2 different shRNAs sequences used. (G) Western blot measuring ATF4 and C3 protein levels in shCtrl and shATF4 OVCAR5 cells grown as monoculture or cocultured with adipocytes. (H) Proliferation of shCtrl and shATF4 OVCAR5 cells, maintained as monoculture (Mono) or following coculture with adipocytes (AdipoCC) (n = 3). ****P < 0.0001 when comparing shCtrl AdipoCC against the other conditions. Values in panels B, C, F, and H are presented as mean ± SD. *P < 0.05, ****P < 0.0001 by 1-way ANOVA with Tukey’s post hoc test (B, C, and F) or 2-way ANOVA with Tukey’s post hoc test (H).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts